In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
In the latest session, Disc Medicine Inc (NASDAQ: IRON) closed at $28.69 down -4.43% from its previous closing price of $30.02. In other words, the price has decreased by -$4.43 from its previous closing price. On the day, 0.57 million shares were traded. IRON stock price reached its highest trading level at $30.055 during the session, while it also had its lowest trading level at $28.09.
Ratios:
For a deeper understanding of Disc Medicine Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 25.96 and its Current Ratio is at 17.06. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.00.
On December 19, 2023, Morgan Stanley Downgraded its rating to Equal-Weight which previously was Overweight and also upped its target price recommendation from $56 to $65.
Raymond James Upgraded its Outperform to Strong Buy on June 09, 2023, whereas the target price for the stock was revised from $50 to $75.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Apr 11 ’24 when White William Richard sold 2,560 shares for $31.80 per share. The transaction valued at 81,407 led to the insider holds 0 shares of the business.
Bitterman Kevin sold 26,157 shares of IRON for $1,922,540 on Mar 05 ’24. The Director now owns 677,503 shares after completing the transaction at $73.50 per share. On Jan 23 ’24, another insider, Bitterman Kevin, who serves as the Director of the company, sold 102,500 shares for $67.65 each. As a result, the insider received 6,934,125 and left with 198,326 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, IRON now has a Market Capitalization of 708097920 and an Enterprise Value of 349817696.
Stock Price History:
The Beta on a monthly basis for IRON is 0.48, which has changed by -0.038860977 over the last 52 weeks, in comparison to a change of 0.2006725 over the same period for the S&P500. Over the past 52 weeks, IRON has reached a high of $77.60, while it has fallen to a 52-week low of $24.89. The 50-Day Moving Average of the stock is -48.64%, while the 200-Day Moving Average is calculated to be -46.49%.
Shares Statistics:
For the past three months, IRON has traded an average of 454.57K shares per day and 417380 over the past ten days. A total of 24.68M shares are outstanding, with a floating share count of 12.82M. Insiders hold about 48.05% of the company’s shares, while institutions hold 51.79% stake in the company. Shares short for IRON as of 1711584000 were 1859500 with a Short Ratio of 4.09, compared to 1709164800 on 1188787. Therefore, it implies a Short% of Shares Outstanding of 1859500 and a Short% of Float of 8.790000000000001.
Earnings Estimates
The stock of Disc Medicine Inc (IRON) is currently being evaluated by 7 analysts who are actively contributing to its market rating.On average, analysts expect EPS of -$1 for the current quarter, with a high estimate of -$0.76 and a low estimate of -$1.22, while EPS last year was -$1.2. The consensus estimate for the next quarter is -$1.04, with high estimates of -$0.8 and low estimates of -$1.27.
Analysts are recommending an EPS of between -$3.24 and -$7.54 for the fiscal current year, implying an average EPS of -$4.67. EPS for the following year is -$5.26, with 8 analysts recommending between -$4.33 and -$7.04.
